Dr. Don Coltart is an organic and medicinal chemist with expertise in total synthesis and methodology development. Dr. Coltart completed postdoctoral studies at the Memorial Sloan-Kettering Cancer Center and Columbia University as a Cancer Research Institute Cancer Immunology, National Science and Engineering Research Counsel of Canada, and Alberta Heritage Foundation for Medical Research Fellow. He began his independent academic career at Duke University in 2004 as an assistant professor and moved to the University of Houston in 2012, where he became a tenured associate professor. During his academic career, Dr. Coltart worked on the development of anti-HIV compounds, small molecule protein-protein interaction inhibitors of Cdc25 phosphatase, and gylcopeptide cancer vaccines. He has extensive experience in grant writing and has secured over $3.9 million in independent funding from various government and private agencies, including the National Science Foundation, the Department of Defense, and the American Chemical Society. Dr. Coltart has served on study sections for the National Institutes of Health, the National Science Foundation, the American Cancer Society, and the American Chemical Society. Don has over 60 peer-reviewed publications, has served as a referee for numerous journals, and has lectured at over 65 universities and conferences. Dr. Coltart has also been recognized for his teaching excellence at both the undergraduate and graduate level, where he has developed innovative programs aimed at improving learning experiences and student success. In his free time Don enjoys drumming, collecting vintage drums, exercising, traveling, and scuba diving.
Education: B.S. in Biochemistry and Masters in Organic Chemistry from the University of Manitoba; Ph.D. in Organic Chemistry from the University of Alberta.